Clinical trials
Withdrawn Lymphoma, B-Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| ADC Therapeutics S.A. | 1 |
| Academic and Community Cancer Research United | 1 |
| Ahmed Galal, MD | 1 |
| Celgene | 1 |
| Children's Hospital Medical Center, Cincinnati | 1 |
| Fred Hutchinson Cancer Center | 1 |
| GlaxoSmithKline | 1 |
| ImmunityBio, Inc. | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, B-Cell | 16 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 3 |
| Lymphoma | 3 |
| Lymphoma, Mantle-Cell | 3 |
| Lymphoma, Non-Hodgkin | 3 |
| Waldenstrom Macroglobulinemia | 2 |
| Acquired Immunodeficiency Syndrome | 1 |
| Burkitt Lymphoma | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.